Sick & Co. is a business consulting firm focused on the regulated cannabis industry in the United States. Its core clients include entrepreneurs, licensed operators, and investors. According to the website, its services cover license applications, regulatory compliance, real estate and municipal approvals, market entry, social equity applications, and license M&A transactions. It is worth noting that the scraped content does not indicate that Sick & Co. is a SaaS or enterprise software product; it is closer to a professional services firm.
Its core service areas revolve around the full lifecycle of cannabis licensing: entity formation, site selection, ownership structure, and business planning before application; operational plans, security plans, narrative materials, social equity documentation, and deficiency responses during the application stage; and post-licensing support such as Metrc seed-to-sale tracking, advertising compliance, packaging and labeling, recordkeeping, inspection readiness, and violation response. On the real estate side, it covers zoning analysis, community boards, municipal approvals, and lease-structure consulting. For transactions, it supports buyer/seller due diligence, ownership transfers, TPI rules, and regulatory approvals.
The website only states that most application projects are quoted on a fixed-fee basis, with scope determined by license type, market, and complexity, emphasizing the avoidance of unexpected hourly billing. It does not publish standard packages, specific prices, payment methods, contract terms, or service SLAs, nor does it provide a free plan, trial, or self-service purchasing option. As a result, prospective buyers need to request a consultation to obtain scope and pricing.
Its strengths lie in deep vertical industry expertise, with coverage across multiple markets including New York, New Jersey, Michigan, California, Colorado, Ohio, Delaware, Minnesota, Rhode Island, and Washington, D.C., as well as forward-looking commentary on emerging markets such as Virginia and Pennsylvania. Its service chain is relatively comprehensive, making it especially suitable for highly regulated and strongly localized licensing and compliance scenarios. The limitation is that it is not a software platform and lacks key SaaS-related information such as team permissions, cloud deployment, APIs, developer support, third-party system integrations, and data security certifications. Delivery may also depend heavily on the experience of individual consultants.
Sick & Co. is better suited to companies and investors planning to enter the U.S. cannabis market, apply for state-level licenses, acquire licenses, or build a compliance framework. It is not suitable for users looking for general-purpose business management software. The text does not provide information about access from China, and payment methods are also unknown. For Chinese clients, additional assessment is needed around U.S. cannabis industry law, cross-border capital movement, banking services, and local compliance risks. Alternatives are typically a combination of U.S.-based cannabis law firms, compliance consulting firms, or general-purpose GRC/project management tools.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on sickandco.com official site.
sickandco.com is an United States SaaS Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach sickandco.com directly.